July 12, 2021 10:40 AM EDTUpdated July 15, 08:32 AM

After questions surrounding funding, ReiThera reveals high antibody response for Covid-19 jab in PhII study

Josh Sullivan

The Italian government saved drugmaker ReiThera’s Covid-19 candidate efforts in May when it threw its support and money behind the company’s own vaccine in the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

After questions surrounding funding, ReiThera reveals high antibody response for Covid-19 jab in PhII study

Josh Sullivan

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

Versant unveils Light Horse with $62M and a partnership with Novartis

After lackluster 2024, biopharma industry prays stalled M&A will finally move into gear

Aiolos team reunites with $411M for new biotech with obesity drugs from China

Exclusive: First-of-its-kind infant DNA edit leads to apparent cure in disease that set back field 25 years ago

Cell therapy startup A2 Biotherapeutics nets $80M Series C

Leyden Labs gets $70M to test if nasal sprays can help protect against viruses

Af­ter ques­tions sur­round­ing fund­ing, Re­i­Thera re­veals high an­ti­body re­sponse for Covid-19 jab in PhII study

Sign up to read this article for free.

more like this

Bachem

Bubendorf, BL, Switzerland

After questions surrounding funding, ReiThera reveals high antibody response for Covid-19 jab in PhII study